Valvular & structural heart disease

Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study

Eur Heart J Qual Care Clin OutcomesPublished registry-based nationwide cohort study

Authors' conclusion

Adverse events, particularly major bleeding, are common in patients with AF following mechanical AVR, and mortality is high. Suboptimal TTR appears to predict bleeding episodes, ischaemic stroke, and death, and it could be useful in high-risk patient identification and targeting of preventive strategies.

Study context

Population
Patients diagnosed with atrial fibrillation (AF) during 2007–18 in Finland undergoing mechanical aortic valve replacement (AVR) before or after the AF diagnosispatients with mechanical AVR and AF either before (41.2%) or after (58.8%) the operation
Participants
1,086 patients
Exposure
Quality of vitamin K antagonist (VKA) therapy (time in therapeutic range (TTR)) and bleeding and ischaemic events following mechanical AVR
Outcome
Cumulative incidence of adverse events
Follow-up
10 years after AVR

Main finding

As reported in the abstract

Significant bleeding

27.9%

Intracranial haemorrhage

5.8%

Ischaemic stroke

12.8%

Myocardial infarction

7.2%

Observational data: associations, not effects.

Further findings

Bleeding occurrence

aHR (CI)P value
TTR < 80% with INR target 2.0-3.5Higher bleeding occurrence with TTR < 80%1.97 (1.39–2.79)P < 0.001

Stroke occurrence

aHR/standard deviation (CI)P value
TTR with INR target ≥2.0Associated with higher stroke occurrence1.22 (1.01–1.46)P = 0.035

Mortality · 10 years

aHR (CI)P value
TTR <80%Higher mortality with TTR <80%2.74 (2.00–3.76)P < 0.001
Mortality — Mortality
28.9%/10 years

Original publication

Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study. Eur Heart J Qual Care Clin Outcomes. Published 14 May 2025. doi:10.1093/ehjqcco/qcaf028

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.